ClinicalTrials.Veeva

Menu

The Impact of Hyperbaric Oxygen Therapy on Vocal Performance in Professional Singers

S

Shamir Medical Center (Assaf-Harofeh)

Status

Enrolling

Conditions

Vocal Cord Strain (Disorder)

Treatments

Device: Device: hyperbaric oxygen therapy

Study type

Interventional

Funder types

Other

Identifiers

NCT07879040
0098-24

Details and patient eligibility

About

The aim of the current study is to evaluate the Impact of Hyperbaric Oxygen Therapy on Vocal Performance in Professional Singers

Full description

Professional singers frequently face occupational risks that affect the health and function of their vocal folds. Vocal fold pathologies such as vocal folds edema, nodules, polyps, laryngitis, and muscle tension dysphonia are common among singers and can lead to significant alterations in voice quality and performance endurance. Traditional therapeutic approaches often include voice rest, vocal training, and in some cases, pharmacological interventions or surgery. However, these methods can be either only partially effective, require extended downtime, which is impractical for professional singers, or expose the singer to potentially significant side effects as in the case of the commonly used steroids interventions.

Hyperbaric oxygen therapy (HBOT) has emerged as a potential innovative treatment for enhancing tissue healing and managing various medical conditions. Research has demonstrated HBOT's efficacy in enhancing tissue repair and modulating inflammatory responses, making it a compelling candidate for treating vocal fold injuries. Despite its potential, the application of HBOT in improving vocal fold function has not been thoroughly investigated. This study aims to fill this gap by evaluating the effectiveness of HBOT in enhancing vocal performance, through a prospective, randomized, controlled design. This research will provide robust evidence of the potential benefits of HBOT, offering an alternative or adjunct therapy that could improve the management of vocal health in the singing profession.

In the following text, we will review the physiology of the vocal folds, the common pathophysiology in professional singers, and the physiological effect of the new protocols of HBOT.

Enrollment

70 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Age between 18-70
  2. Professional singers for at least 3 months.
  3. Subject willing and able to read, understand and sign an informed consent.

Exclusion criteria

  1. Inability to attend scheduled clinic visits and/or comply with the study protocol
  2. Substance use at baseline.
  3. Any sever illness that based on the physician expected to deteriorate in the upcoming year.
  4. HBOT for any reason prior to study enrolment
  5. Chest pathology incompatible with pressure changes (including active asthma or COPD)
  6. Ear or Sinus pathology incompatible with pressure changes (above 3 otolaryngologist visits a year)
  7. An inability to perform an awake brain MRI
  8. Active smoking
  9. Participation in another study

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

70 participants in 1 patient group

Active Comparator: hyperbaric oxygen therapy (HBOT) active treatment
Experimental group
Description:
The HBOT protocol consists of 40 daily sessions, five times per week, within a three months' period. Then there will be a follow-up period for 3 months without any investigated intervention. each session lasting 90 minutes, of 100% oxygen at 2 ATA and 5-minute air breaks every 20 minutes.
Treatment:
Device: Device: hyperbaric oxygen therapy

Trial contacts and locations

1

Loading...

Central trial contact

Shai Efrati, Prof

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems